Literature DB >> 8793154

Adjunctive carbamazepine or lithium carbonate in therapy-resistant chronic schizophrenia.

C Simhandl, K Meszaros, E Denk, K Thau, A Topitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8793154     DOI： 10.1177/070674379604100513

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  4 in total

1.  Factors associated with expression of extrapyramidal symptoms in users of atypical antipsychotics.

Authors:  Susana Barbosa Ribeiro; Aurigena Antunes de Araújo; Caroline Addison Xavier Medeiros; Katarina Melo Chaves; Maria do Socorro Costa Feitosa Alves; Antonio Gouveia Oliveira; Rand Randall Martins
Journal:  Eur J Clin Pharmacol       Date:  2016-11-26       Impact factor: 2.953

Review 2.  Carbamazepine for schizophrenia.

Authors:  Stefan Leucht; Bartosz Helfer; Markus Dold; Werner Kissling; John McGrath
Journal:  Cochrane Database Syst Rev       Date:  2014-05-02

Review 3.  The effectiveness of anticonvulsants in psychiatric disorders.

Authors:  Heinz C R Grunze
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

Review 4.  Lithium for schizophrenia.

Authors:  Stefan Leucht; Bartosz Helfer; Markus Dold; Werner Kissling; John J McGrath
Journal:  Cochrane Database Syst Rev       Date:  2015-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.